Cost & Access11 min readUpdated August 28, 2026

    Compounded Semaglutide Cost: What You Actually Pay Per Month (2026)

    Advertised prices for compounded semaglutide range from about $60 to $200 per month, but the number on the banner is rarely the number on your card statement. Here is what all-in really means, why programs differ by $100/month for the same service, and what to ask before you pay anyone.

    Quick answer

    Across the major US telehealth programs we verified in August 2026, compounded semaglutide costs roughly $99 to $200 per month all-in once membership fees, consultations, dose increases, and shipping are counted. Trimi's annual plan is a flat $99/month, covering the medication, a licensed provider, and free overnight shipping once compounded; the trade-off is that the annual plan is a 12-month commitment, backed by a 6-month money-back promise.

    Programs that advertise lower “starting at” prices usually bill a monthly membership fee on top, raise the price as your dose increases, or require prepaying a full year upfront. Individual results vary.

    Written by Trimi Medical Team. Medically reviewed by Dr. Sean Arora, MD. Updated August 28, 2026. Competitor pricing estimates last verified August 2026 against each provider's public pricing pages — verify current rates with each provider before enrolling, as prices and plan structures change.

    The number that matters: your 12-month total

    Most people who search for compounded semaglutide pricing compare headline numbers. That is the mistake the pricing pages are designed for. The only comparison that holds up is the all-in 12-month total: medication at your actual dose, plus every membership fee, consult fee, shipping charge, and supply cost, divided by twelve.

    Run that math and the market compresses into a narrower band than the ads suggest. In our August 2026 check of public pricing pages, flat all-in programs sat at $99–$197/month, and membership-model programs landed in a similar range once the platform fee and medication were added together — with the difference that their totals climb as the dose does.

    Semaglutide is taken long-term, and the dose typically increases over the first several months of treatment. A price that looks low at the starting dose can be a very different number at maintenance. That single detail explains most of the confusion behind “why was I charged more this month?” threads. If you want the deeper background on why compounded programs can price this far below what people expect, see why compounded semaglutide costs less than people assume.

    Compounded semaglutide, $99/month all-in on Trimi's annual plan

    One flat price covers the medication, a licensed provider through the Arora Health 50-state network, and free overnight shipping once compounded — same price at every prescribed dose, no separate membership or consult fees. The annual plan is a 12-month commitment backed by a 6-month money-back promise. Prescriptions are prepared per individual prescription by state-licensed 503A pharmacies (VialsRx, Texas State Board of Pharmacy #35264, and GreenwichRx); compounded preparations are not FDA-approved as drugs, and a licensed provider decides whether treatment is appropriate for you.

    The four billing models behind every price you'll see

    Every compounded semaglutide price on the internet is one of these four structures wearing different branding. Identify the model first and the price becomes easy to decode.

    Flat all-in monthly

    One price covers the medication, provider care, and shipping. The price does not change with your dose.

    Example: Trimi: $99/mo on the annual plan (a 12-month commitment)

    Watch for: Confirm the commitment length and the refund terms before you enroll.

    Membership plus medication

    A recurring platform fee, with the medication billed separately on top at its own price.

    Example: Mochi Health: $79/mo membership, with compounded semaglutide injection listed “starting at $60” on top (verified Aug 2026)

    Watch for: Add both lines together, and ask what the medication costs at your maintenance dose, not the starting dose.

    Prepaid multi-month plans

    A lower monthly headline number that requires paying many months upfront in full.

    Example: Henry Meds: injectable compounded semaglutide listed at $197/mo with a 12-month plan paid upfront in full (verified Aug 2026)

    Watch for: Work out the true upfront outlay and the cancellation policy before you pay.

    Dose-tiered pricing

    The monthly price climbs as your prescribed dose increases during titration.

    Example: “Starting at” prices on several platforms apply to the lowest dose only

    Watch for: Ask for the full price schedule from the starting dose through maintenance.

    None of these models is dishonest by itself. Membership programs bundle coaching and community features some patients genuinely want; prepaid plans reward patients who are certain they will stay a full year. The problem is only that the four models make headline prices incomparable — a “starting at $60” medication price sits on top of a $79/month membership, while a “$99” can already be the entire bill.

    The market is also shifting under these prices: some large telehealth platforms have moved away from compounded semaglutide entirely and now center their weight-loss programs on FDA-approved brand medications (Ro's program is one example as of August 2026). That makes it worth confirming that a provider still offers the compounded route at all before comparing its pricing.

    What actually drives the cost differences

    Membership and platform fees

    Some programs separate the platform from the medication, so the advertised medication price excludes a recurring monthly membership line. Mochi Health's structure is the clearest example we verified in August 2026: a $79/month membership, with medications billed separately and explicitly excluded from the membership subscription. Neither line alone is your cost — the sum is.

    Per-dose versus flat pricing

    Compounding pharmacies price vials by strength, so programs that pass this through charge more as your prescribed dose increases during titration. Flat-price programs absorb it instead: Trimi charges $99/month at every prescribed dose. Over a normal titration schedule, this one variable can swing your second-half-of-year costs more than any other line item.

    Consultation and follow-up fees

    A licensed provider must evaluate you before any prescription is written, and dose adjustments require clinical review. Some programs bundle all of this into the monthly price; others bill the initial visit, follow-ups, or both separately. A single unbundled consult fee can erase a month of apparent savings.

    Shipping, supplies, and commitment length

    Cold-chain shipping and injection supplies (syringes, alcohol swabs, a sharps container) are included in some programs and billed in others. Commitment length matters too: annual pricing is usually the lowest monthly rate but is a real commitment — Trimi's $99/month rate is the annual plan, a 12-month commitment backed by a 6-month money-back promise, while month-to-month plans elsewhere cost more but end sooner.

    The reference point: Trimi's flat $99/month

    Trimi (founded May 2024, headquartered in New York City) prices compounded semaglutide the simplest way the market allows: $99/month on the annual plan, all-in. The price includes the medication at every prescribed dose, evaluation and ongoing care from a licensed provider in the Arora Health 50-state network, and shipping — medication ships free overnight once compounded.

    What the $99/month covers:

    • Compounded semaglutide at your prescribed dose — same price from the starting dose through maintenance
    • Initial evaluation and ongoing care from a licensed provider (Arora Health, 50-state network)
    • Free overnight shipping once compounded
    • No separate membership, platform, consultation, or dose-change fees

    The honest trade-off: the annual plan is a 12-month commitment. Trimi backs it with a 6-month money-back promise rather than a cancel-anytime structure, so it fits patients planning a sustained course of treatment, which is how semaglutide is designed to be used. Prescriptions are prepared per individual prescription by state-licensed 503A compounding pharmacies — VialsRx (Texas State Board of Pharmacy #35264) and GreenwichRx — and compounded preparations are not FDA-approved as drugs. A licensed provider reviews your health history and decides whether treatment is appropriate; pricing only matters if the answer is yes.

    If you are weighing semaglutide against tirzepatide, Trimi's compounded tirzepatide is $125/month on the same annual structure — the full breakdown is in our compounded tirzepatide cost guide, and our tirzepatide vs semaglutide comparison covers how the two medications differ clinically.

    Seven questions to ask any provider before you pay

    These questions convert any pricing page, whatever its billing model, into the same comparable number.

    1. What is my total monthly cost at the maintenance dose, not the starting dose?
    2. Is there a separate membership, platform, or subscription fee on top of the medication?
    3. Do you charge for the initial consultation or for follow-up visits?
    4. Is shipping included, and are injection supplies (syringes, swabs, sharps container) included?
    5. Which licensed pharmacy compounds my prescription, and in which state is it licensed?
    6. How long is the commitment, and what are the refund terms if I stop?
    7. Does the price change if my provider adjusts my dose?

    When a low price is a warning sign

    Cost research and safety research end up being the same research. According to the FDA's drug alert on unapproved GLP-1 drugs, the agency had received 990 reports of adverse events associated with compounded semaglutide as of May 31, 2026, and has separately received multiple adverse event reports — some requiring hospitalization — that may be related to dosing errors from patients measuring and self-administering incorrect doses. The FDA also lists “deep discounts or prices that seem too good to be true” among its telehealth red flags, and states that semaglutide salt forms should not be used in compounding.

    No prescription or provider evaluation required before purchase

    Vials sold as “for research purposes” or “not for human consumption”

    No named, verifiable state-licensed pharmacy dispensing the prescription

    Prices dramatically below the verified telehealth market without explanation

    A fair price from a licensed pharmacy beats a rock-bottom price from an unverifiable one, every time. Our compounded semaglutide cost and safety guide covers the safety side in depth, and this guide shows how to verify any compounding pharmacy's license in about five minutes.

    What you're paying for: the evidence in brief

    Clinical trials show a 14.9% average body-weight reduction over 68 weeks with FDA-approved semaglutide 2.4 mg alongside diet and exercise changes (STEP 1, Wilding et al., New England Journal of Medicine, 2021). Compounded semaglutide preparations have not been studied in clinical trials of their own, and individual results vary. For a fuller picture of what trial results do and don't mean for a typical patient, see our semaglutide weight loss results guide or start with the GLP-1 beginner's guide.

    Per FDA guidance on compounding, compounded drugs are not reviewed by the agency for safety, effectiveness, or quality before marketing, and should be dispensed by a state-licensed pharmacy against an individual prescription. That is the floor any price must clear before it is worth comparing.

    Frequently asked questions

    How much does compounded semaglutide cost per month?

    Across the major US telehealth programs we verified in August 2026, compounded semaglutide runs roughly $99 to $200 per month once membership fees, consultations, and shipping are counted. Trimi's annual plan is a flat $99/month all-in (medication, licensed provider care, and free overnight shipping once compounded; a 12-month commitment). Membership-model programs advertise lower medication prices but add a monthly platform fee on top, and “starting at” prices typically rise with dose. Verify current rates directly with any provider before enrolling.

    Why do compounded semaglutide prices vary so much between providers?

    Four billing models drive most of the spread: flat all-in monthly pricing, membership fees with medication billed separately, prepaid multi-month plans with lower headline rates, and dose-tiered pricing that climbs during titration. Two programs advertising similar numbers can differ by $50-$100/month once you add platform fees, consult charges, shipping, and dose increases. Always compare the 12-month total, not the headline.

    Does the price go up as my semaglutide dose increases?

    It depends on the billing model. Dose-tiered programs charge more as your prescribed dose increases, which is why “starting at” prices can be misleading. Trimi charges the same $99/month at every prescribed dose on the annual plan. Before enrolling anywhere, ask for the full price schedule from the starting dose through the maintenance dose.

    Does insurance cover compounded semaglutide?

    Generally no. Insurance plans typically cover only FDA-approved drugs, so compounded semaglutide is almost always a cash-pay purchase. Many patients can use HSA or FSA funds when the medication is prescribed by a licensed provider, but confirm eligibility with your plan administrator first.

    What is included in Trimi's $99 per month?

    Trimi's $99/month annual plan covers the compounded semaglutide medication, evaluation and ongoing care from a licensed provider in the Arora Health 50-state network, and free overnight shipping once compounded, at the same price at every prescribed dose. The annual plan is a 12-month commitment backed by Trimi's 6-month money-back promise. Prescriptions are prepared per individual prescription by state-licensed 503A pharmacies (VialsRx, Texas State Board of Pharmacy #35264, and GreenwichRx); compounded preparations are not FDA-approved as drugs, and a licensed provider decides whether treatment is appropriate for you.

    Is very cheap compounded semaglutide safe to buy?

    Price alone is not a safety screen, but the FDA lists deep discounts and prices that seem too good to be true among its telehealth red flags for unapproved GLP-1 drugs. Avoid any source that skips a prescription from a licensed provider, sells vials labeled “for research purposes,” or uses semaglutide salt forms, which the FDA says should not be used in compounding. Legitimate compounded semaglutide is dispensed only by a state-licensed pharmacy against an individual prescription.

    How much weight do people lose on semaglutide?

    Clinical trials of FDA-approved semaglutide 2.4 mg (STEP 1, New England Journal of Medicine 2021) reported a 14.9% average body-weight reduction over 68 weeks alongside diet and exercise changes. Compounded semaglutide preparations have not been studied in clinical trials of their own, and individual results vary.

    Know your real monthly number

    Compounded semaglutide, $99/month all-in on the annual plan

    Medication, licensed provider, and free overnight shipping once compounded — same price at every dose. Annual plan is a 12-month commitment with a 6-month money-back promise. A licensed provider determines eligibility; individual results vary.

    Check your eligibility

    Sources

    1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). NEJM 2021;384:989-1002.
    2. US FDA. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. Drug alert; adverse-event counts as of May 31, 2026. Accessed August 28, 2026.
    3. Henry Meds public weight-management pricing page. Accessed August 28, 2026.
    4. Mochi Health public membership and treatment pricing pages. Accessed August 28, 2026.
    5. Ro public weight-loss program page. Accessed August 28, 2026.

    Medical disclaimer: This article is for informational purposes only and is not medical advice. Semaglutide is a prescription GLP-1 receptor agonist. Common side effects include nausea, vomiting, diarrhea, and constipation; less common but serious risks include pancreatitis, gallbladder disease, acute kidney injury (often from dehydration), and low blood sugar when combined with certain diabetes medications. Semaglutide carries a boxed warning for thyroid C-cell tumors observed in rodent studies and is contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN 2. Compounded semaglutide is prepared per individual prescription by a state-licensed pharmacy and is not FDA-approved as a drug. A licensed provider determines whether treatment is appropriate for you. Individual results vary. Always consult a licensed provider before starting, changing, or stopping any medication.

    What does the published clinical evidence show for compounded semaglutide?

    Peer-reviewed evidence: Adults with overweight or obesity on semaglutide 2.4 mg achieved a mean body weight reduction of approximately 14.9% at 68 weeks, compared with 2.4% on placebo. (Source: STEP 1, NEJM 2021). Trimi offers compounded semaglutide starting at $99/month on the annual plan, dispensed by 503A community sterile compounding pharmacies (VialsRx, Texas pharmacy license #35264, and GreenwichRx). Results vary by individual; eligibility is determined by a licensed clinician.

    Adults with overweight or obesity on semaglutide 2.4 mg achieved a mean body weight reduction of approximately 14.9% at 68 weeks, compared with 2.4% on placebo., STEP 1, NEJM 2021
    Approximately 86% of patients on continued semaglutide treatment maintained ≥5% body-weight reduction from baseline through 68 weeks, vs 33% in the placebo-switch arm., STEP 4, JAMA 2021
    Semaglutide 2.4 mg reduced major adverse cardiovascular events (MACE) by 20% over a mean 39.8-month follow-up in adults with overweight/obesity and pre-existing cardiovascular disease without diabetes., SELECT, NEJM 2023

    Key Takeaways

    • Adults with overweight or obesity on semaglutide 2.4 mg achieved a mean body weight reduction of approximately 14.9% at 68 weeks, compared with 2.4% on placebo. (Source: STEP 1, NEJM 2021)
    • Approximately 86% of patients on continued semaglutide treatment maintained ≥5% body-weight reduction from baseline through 68 weeks, vs 33% in the placebo-switch arm. (Source: STEP 4, JAMA 2021)
    • Semaglutide 2.4 mg reduced major adverse cardiovascular events (MACE) by 20% over a mean 39.8-month follow-up in adults with overweight/obesity and pre-existing cardiovascular disease without diabetes. (Source: SELECT, NEJM 2023)
    • The brand finished products (Wegovy and Ozempic) are FDA-approved and manufactured at commercial scale. Trimi's compounded semaglutide is prepared per individual prescription by 503A community sterile compounding pharmacies and is not itself FDA-approved as a drug.
    • Eligibility requires evaluation by a licensed clinician: BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease). Contraindications include personal or family history of medullary thyroid carcinoma, MEN 2 syndrome, pancreatitis, severe gastrointestinal disease, severe renal impairment, pregnancy, and breastfeeding.
    • Common GLP-1 receptor agonist adverse effects include nausea, vomiting, diarrhea, constipation, and gallbladder events. Dose titration over weeks improves tolerability. Severe gastrointestinal symptoms may cause dehydration and increase acute kidney injury risk.
    • This is general information based on the cited evidence, not medical advice. Treatment decisions require evaluation by a licensed clinician familiar with your individual medical history, BMI, and comorbidities.

    Wegovy vs. Trimi Compounded Semaglutide, 2026 Comparison

    Wegovy is the FDA-approved brand finished product from Novo Nordisk. Trimi dispenses compounded semaglutide via 503A sterile compounding pharmacies against an individual prescription; compounded preparations are not FDA-approved as drugs, and Trimi's flat rate is $99/month on the annual cash-pay cost.

    Wegovy vs. Trimi Compounded Semaglutide, 2026 Comparison
    Wegovy (Novo Nordisk)Trimi Compounded Semaglutide
    Active ingredientSemaglutideSemaglutide
    Cash-pay priceManufacturer-set list price (see NovoCare for current pricing)$99/month (annual plan, 12-month commitment)
    Insurance coverageRequired (often denied for weight loss)Cash-pay, no insurance needed
    FDA approvalFDA-approved finished product (2021)Compounded preparation (active ingredient FDA-approved)
    Dose customizationFixed factory dosesPer-prescription compounded doses
    PharmacyRetail / specialty pharmacyVialsRx (TX #35264), GreenwichRx (503A)
    Clinician accessPrimary care or specialist referralArora Health 50-state telehealth
    Average weight loss (active ingredient)14.9% at 68 weeks (STEP 1)Not studied in trials of its own; figures are from the FDA-approved product

    Source: STEP 1 Trial (Wilding et al., NEJM 2021) + Trimi pricing 2026

    Medically Reviewed

    TMRT

    Trimi Medical Review Team

    Clinical review workflow for GLP-1 safety, dosing, and access content

    Team-based medical review process documented in Trimi's Medical Review Policy

    Last reviewed: August 28, 2026

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Medically reviewed by Trimi Medical Review Team, Clinical review workflow for GLP-1 safety, dosing, and access content

    What real Trimi patients say

    Verbatim quotes from Trimi's Facebook and Reddit community reviews. First name and last initial preserved per editorial policy.

    It's only been 2 weeks since I've been taking the VialsRx meds from Trimi. The medication showed up pretty quickly (about 4 days after getting approval from Trimi prescriber) and I received 3 vials for my first 3 months on the subscription. For the price and convenience my take is that Trimi and VialsRx is good.

    Outcome: 4-day delivery; 3 vials for first 3 months; price + convenience verdict positive

    Really great customer service! Fast shipment.

    Outcome: Fast shipment

    - Amy K.Facebook

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2032183
    2. Rubino D, Abrahamsson N, Davies M, et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA.Read StudyDOI: 10.1001/jama.2021.3224
    3. Garvey WT, Batterham RL, Bhatta M, et al. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine.Read StudyDOI: 10.1038/s41591-022-02026-4
    4. Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. (2023). Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2307563
    5. Marso SP, Bain SC, Consoli A, et al. (2016). Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa1607141
    6. Perkovic V, Tuttle KR, Rossing P, et al. (2024). Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (FLOW). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2403347

    Was this article helpful?

    Keep Reading

    Clinician-reviewed Trimi guide to semaglutide: clinical evidence, dosing considerations, side-effect management, and patient guidance. Plus how Trimi's compounded semaglutide option compares to brand alternatives.

    How the Inflation Reduction Act changes Medicare GLP-1 costs in 2026: the Part D out-of-pocket cap, the negotiation timeline, prior auth, and appeals.

    Compounded semaglutide telehealth providers ranked by true all-in monthly cost in 2026. Trimi $99/mo annual #1, state-licensed 503A pharmacy (VialsRx #35264, GreenwichRx), flat maintenance pricing.

    Ro semaglutide review for 2026: $45 first month Body membership then $145/mo, compounded semaglutide at roughly $145 to $199/mo by dose, and our 3.6/5 verdict.

    Compounded semaglutide $99/mo all-in (annual)

    Start visit

    Start your GLP-1 journey, from $99/mo

    Get Started